FDAlogo 300The global COVID-19 pandemic will likely impact current and planned clinical trials, including those using focused ultrasound. The guidance released by the US Food and Drug Administration (FDA) acknowledges this likelihood and focuses on the safety of trial participants and medical staff while also maintaining compliance and good clinical practice. The considerations outline alternative methods of data collection, such as via phone or email, and additional safety monitoring.

Read the Guidance >

See Additional Relevant COVID-19 Resources >

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email